Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Leder

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|March 22, 2001
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patientsH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2001
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Bone Marrow Transplantation|September 1, 2000
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
European Journal of Haematology|March 1, 1995
Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevanceH Ottinger, C Belka, G Kozole, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1996
Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric studyJ Thiele, T Zirbes, H M Kvasnicka, et al.
American Journal of Hematology|September 1, 1995
Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot studyJ Thiele, H M Kvasnicka, N Niederle, et al.
The Journal of Pathology|March 1, 1997
Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapyJ Thiele, T K Zirbes, J Lorenzen, et al.
Hematopathology and Molecular Hematology|January 1, 1996
Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CMLJ Thiele, H M Kvasnicka, T K Zirbes, et al.
Annals of Hematology|March 1, 1995
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsiesJ Thiele, H M Kvasnicka, N Niederle, et al.
Leukemia & Lymphoma|February 16, 2000
Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|March 22, 2001
Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patientsH M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2001
Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
Bone Marrow Transplantation|September 1, 2000
Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patientsJ Thiele, H M Kvasnicka, D W Beelen, et al.
European Journal of Haematology|March 1, 1995
Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevanceH Ottinger, C Belka, G Kozole, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1996
Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric studyJ Thiele, T Zirbes, H M Kvasnicka, et al.
American Journal of Hematology|September 1, 1995
Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot studyJ Thiele, H M Kvasnicka, N Niederle, et al.
The Journal of Pathology|March 1, 1997
Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapyJ Thiele, T K Zirbes, J Lorenzen, et al.
Hematopathology and Molecular Hematology|January 1, 1996
Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CMLJ Thiele, H M Kvasnicka, T K Zirbes, et al.
Annals of Hematology|March 1, 1995
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsiesJ Thiele, H M Kvasnicka, N Niederle, et al.
Leukemia & Lymphoma|February 16, 2000
Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Pageof 13